Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


08.07.2019

1 Ann Oncol
1 Ann Surg Oncol
6 Anticancer Res
5 BMC Cancer
1 Cancer Res
2 Clin Cancer Res
1 Clin Res Hepatol Gastroenterol
1 Eur J Surg Oncol
5 Gastroenterology
2 Gastrointest Endosc
1 Gut
1 Int J Cancer
2 Int J Colorectal Dis
1 Int J Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
2 Lancet Oncol
1 Oncogene
2 Oncol Rep
2 PLoS One
6 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. TAIEB J, Shi Q, Pederson L, Alberts S, et al
    Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an accent pooled analysis of 7 studies.
    Ann Oncol. 2019 Jul 3. pii: 5527754. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. LAZARUS J, Oneka MD, Barua S, Maj T, et al
    Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells.
    Ann Surg Oncol. 2019 Jun 27. pii: 10.1245/s10434-019-07508.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. CZUMAJ A, Zabielska J, Pakiet A, Mika A, et al
    In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.
    Anticancer Res. 2019;39:3815-3822.
    PubMed     Text format     Abstract available

  4. PARK JH, Zhao M, Oshiro H, Miyake K, et al
    Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
    Anticancer Res. 2019;39:3463-3467.
    PubMed     Text format     Abstract available

  5. KOBUNAI T, Matsuoka K, Takechi T
    ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro.
    Anticancer Res. 2019;39:3565-3570.
    PubMed     Text format     Abstract available

  6. KIM JY, Park G, Krishnan M, Ha E, et al
    Selective Wnt/beta-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
    Anticancer Res. 2019;39:3661-3667.
    PubMed     Text format     Abstract available

  7. LIU Y, Kwon T, Kim JS, Chandimali N, et al
    Peroxiredoxin V Reduces beta-Lapachone-induced Apoptosis of Colon Cancer Cells.
    Anticancer Res. 2019;39:3677-3686.
    PubMed     Text format     Abstract available

  8. GIULIANI J, Bonetti A
    The Onset of Grade >/=3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil.
    Anticancer Res. 2019;39:3967-3969.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. CAVAGNARI MAV, Silva TD, Pereira MAH, Sauer LJ, et al
    Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer.
    BMC Cancer. 2019;19:644.
    PubMed     Text format     Abstract available

  10. NG TH, Sham KWY, Xie CM, Ng SSM, et al
    Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    BMC Cancer. 2019;19:649.
    PubMed     Text format     Abstract available

  11. KAZLAUSKAS A, Darinskas A, Meskys R, Tamasauskas A, et al
    Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    BMC Cancer. 2019;19:197.
    PubMed     Text format     Abstract available

  12. CHEN SH, Tsai HL, Jiang JK, Sung YC, et al
    Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.
    BMC Cancer. 2019;19:640.
    PubMed     Text format     Abstract available

  13. HUMMEL S, Kohlmann W, Kollmeyer TM, Jenkins R, et al
    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    BMC Cancer. 2019;19:190.
    PubMed     Text format     Abstract available


    Cancer Res

  14. RESAR L, Chia L, Xian L
    Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
    Cancer Res. 2018 Apr 4. pii: 0008-5472.CAN-17-3045.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  15. MORRIS VK
    Circulating Tumor DNA in Advanced Anal Cancer: A Blood Biomarker Goes Viral.
    Clin Cancer Res. 2019;25:2030-2032.
    PubMed     Text format     Abstract available

  16. WILLIS JA, Overman MJ, Vilar E
    Mismatch repair-proficient colorectal cancer: finding the right TiME to respond.
    Clin Cancer Res. 2019 Jul 1. pii: 1078-0432.CCR-19-1447.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  17. ZHU K, Wang Y, Liu L, Li S, et al
    Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.
    Clin Res Hepatol Gastroenterol. 2019 Jun 26. pii: S2210-7401(19)30098.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  18. KETELAERS SHJ, Orsini RG, Burger JWA, Nieuwenhuijzen GAP, et al
    Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years.
    Eur J Surg Oncol. 2019 Jun 13. pii: S0748-7983(19)30511.
    PubMed     Text format     Abstract available


    Gastroenterology

  19. BUSHYHEAD D, Rocha FG, Kozarek RA
    Small Bowel Necrosis After Colonoscopy.
    Gastroenterology. 2019;156:e12-e13.
    PubMed     Text format    

  20. REPICI A, Wallace MB, East JE, Sharma P, et al
    Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy.
    Gastroenterology. 2019;156:2198-2207.
    PubMed     Text format     Abstract available

  21. KANDIMALLA R, Ozawa T, Gao F, Wang X, et al
    Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-Risk T1 Colorectal Cancers.
    Gastroenterology. 2019;156:2338-2341.
    PubMed     Text format    

  22. LI ZW, Sun B, Gong T, Guo S, et al
    GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Gastroenterology. 2019;156:2297-2312.
    PubMed     Text format     Abstract available

  23. JOOSTEN SPJ, Mizutani T, Spaargaren M, Clevers H, et al
    MET signaling overcomes EGFR inhibition in normal and colorectal cancer stem cells causing drug resistance.
    Gastroenterology. 2019 Jun 27. pii: S0016-5085(19)41038.
    PubMed     Text format    


    Gastrointest Endosc

  24. BINMOELLER KF
    Underwater EMR without submucosal injection: Is less more?
    Gastrointest Endosc. 2019;89:1117-1119.
    PubMed     Text format    

  25. SHAHIDI N, Bourke MJ
    Endoscopic full-thickness resection for invasive colorectal neoplasia: Hype or here to stay?
    Gastrointest Endosc. 2019;89:1190-1192.
    PubMed     Text format    


    Gut

  26. DE VRIES NL, van Unen V, Ijsselsteijn ME, Abdelaal T, et al
    High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity.
    Gut. 2019 Jul 3. pii: gutjnl-2019-318672. doi: 10.1136/gutjnl-2019-318672.
    PubMed     Text format     Abstract available


    Int J Cancer

  27. HE Y, Theodoratou E, Li X, Din FV, et al
    Effects of common genetic variants associated with colorectal cancer risk on survival outcomes after diagnosis: a large population-based cohort study.
    Int J Cancer. 2019 Jul 4. doi: 10.1002/ijc.32550.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  28. KRAUSE C, Kruis W
    Synchronous pathologic findings in patients with colorectal cancer and preoperative incomplete colonoscopy.
    Int J Colorectal Dis. 2019 Jun 29. pii: 10.1007/s00384-019-03330.
    PubMed     Text format     Abstract available

  29. NISHIKAWA T, Kawai K, Emoto S, Murono K, et al
    The influence of pulmonary comorbidities on treatment choice and short-term surgical outcomes among elderly patients with colorectal cancer.
    Int J Colorectal Dis. 2019 Jun 28. pii: 10.1007/s00384-019-03336.
    PubMed     Text format     Abstract available


    Int J Oncol

  30. YANG W, Shi J, Zhou Y, Liu T, et al
    Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Int J Oncol. 2019 Jun 27. doi: 10.3892/ijo.2019.4833.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  31. EAGLEHOUSE YL, Georg MW, Shriver CD, Zhu K, et al
    Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System.
    J Natl Cancer Inst. 2019 Jul 4. pii: 5528256. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  32. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Response to the Letter to the Editor.
    J Surg Oncol. 2019;119:399.
    PubMed     Text format    


    Lancet Oncol

  33. BEKAII-SAAB TS, Ou FS, Ahn DH, Boland PM, et al
    Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
    Lancet Oncol. 2019 Jun 28. pii: S1470-2045(19)30272.
    PubMed     Text format     Abstract available

  34. HOFHEINZ RD, Stintzing S
    Study evidence confirms current clinical practice in refractory metastatic colorectal cancer: the ReDOS trial.
    Lancet Oncol. 2019 Jun 28. pii: S1470-2045(19)30390.
    PubMed     Text format    


    Oncogene

  35. MISHRA S, Bernal C, Silvano M, Anand S, et al
    The protein secretion modulator TMED9 drives CNIH4/TGFalpha/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.
    Oncogene. 2019 Jun 28. pii: 10.1038/s41388-019-0845.
    PubMed     Text format     Abstract available


    Oncol Rep

  36. ALCANTARA KMM, Garcia RL
    MicroRNA92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Oncol Rep. 2019 Feb 19. doi: 10.3892/or.2019.7020.
    PubMed     Text format     Abstract available

  37. WANG JQ, Tang Y, Li QS, Xiao M, et al
    PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NFkappaB in tumour metastases of colon carcinoma.
    Oncol Rep. 2019;41:2657-2666.
    PubMed     Text format     Abstract available


    PLoS One

  38. GILSON P, Franczak C, Dubouis L, Husson M, et al
    Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    PLoS One. 2019;14:e0219204.
    PubMed     Text format     Abstract available

  39. KARLSSON E, Farahnak P, Franzen E, Nygren-Bonnier M, et al
    Feasibility of preoperative supervised home-based exercise in older adults undergoing colorectal cancer surgery - A randomized controlled design.
    PLoS One. 2019;14:e0219158.
    PubMed     Text format     Abstract available


    World J Surg

  40. LIANG JT, Huang J, Chen TC
    Standardize the Surgical Technique and Clarify the Relevant Anatomic Concept for Complete Mobilization of Colonic Splenic Flexure Using da Vinci Xi((R)) Robotic System.
    World J Surg. 2019;43:1129-1136.
    PubMed     Text format     Abstract available

  41. FARAG A, Mashhour AN, Elbarmelgi MY
    Taeniectomy Versus Transverse Coloplasty as Neorectum After Low Rectal Resection.
    World J Surg. 2019;43:1137-1145.
    PubMed     Text format     Abstract available

  42. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
    Preoperative Leucocyte-Based Inflammatory Scores in Patients with Colorectal Liver Metastases: Can We Count on Them?
    World J Surg. 2019;43:1351-1359.
    PubMed     Text format     Abstract available

  43. PORTALE G, Popesc GO, Parotto M, Cavallin F, et al
    Delayed Colo-anal Anastomosis for Rectal Cancer: Pelvic Morbidity, Functional Results and Oncological Outcomes: A Systematic Review.
    World J Surg. 2019;43:1360-1369.
    PubMed     Text format     Abstract available

  44. HEUS C, Bakker N, Verduin WM, Doodeman HJ, et al
    Impact of Body Composition on Surgical Outcome in Rectal Cancer Patients, a Retrospective Cohort Study.
    World J Surg. 2019;43:1370-1376.
    PubMed     Text format     Abstract available

  45. CAIRNS AL, Schlottmann F, Strassle PD, Di Corpo M, et al
    Racial and Socioeconomic Disparities in the Surgical Management and Outcomes of Patients with Colorectal Carcinoma.
    World J Surg. 2019;43:1342-1350.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: